Developer docs
API playgroundTry for free, no card

Search company profiles

Digbi Health

Full company profile

uuid0000hqt

Namestring
Digbi Health
Legal namestring
FOOD RX AI INC.
Websiteurl
digbihealth.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Digbi Health (legal entity FOOD RX AI INC.) is a precision biology digital therapeutics company headquartered at 800 El Camino Real West, Mountain View, California. Founded in 2017 by Ranjan Sinha, the company targets chronic metabolic, gastrointestinal, and mental-health conditions — primarily obesity, type 2 diabetes, IBS/GERD, and anxiety — that disproportionately drive employer healthcare spend. Its core offering is a multi-modal personalization platform that combines at-home genetic testing (600K variants via saliva), gut-microbiome analysis (stool swab through CLIA-compliant partner Akesogen), blood biomarkers, and continuous glucose monitor data into a unified member profile driving food-as-medicine recommendations.

The product portfolio spans Digbi Cares (obesity/metabolic/digestive), Digbi Digestive (GI-specific), Digbi Control (weight-loss subscription with personalized prebiotics at $68.99/month), and the GLP Compass suite — including GLP-Fit (Sep 2023) and Digbi RxFund (Mar 2026) — that integrates GLP-1 medication access and lifecycle management. A consumer subscription layer ($499 Digbi Cares one-time, or $45.08/month via Affirm financing) sits alongside a B2B enterprise channel with self-insured employers, health plans, and TPAs priced on milestone-based contracts with 100% of fees at risk against ROI claims.

Digbi monetizes through enterprise subscriptions (custom annual contracts with ROI guarantees, 9X actuarially validated ROI and $15,480 PMPY savings reported across seven employers), direct-to-consumer subscriptions and one-time kit sales, and GLP-1 transaction economics via the RxFund platform. Reported outcomes include 9.7% average weight loss without drugs, 18% with GLP-1s, 84% GI symptom improvement, 1.2% HbA1c reduction, and 63% mental-health improvement. Named enterprise customers include Blue Shield of California (23,500+ Wellvolution members), County of Ventura, and 300+ self-insured employers; strategic partners include Novo Nordisk, LabCorp, Collective Health, Health Transformation Alliance, Personify Health, and Dexcom.

Short descriptiontext

Digbi Health is a precision biology digital therapeutics company providing personalized chronic-disease care (obesity, type 2 diabetes, GI, and mental health) by integrating genetic, gut microbiome, blood biomarker, and CGM data for self-insured employers, health plans, and individual consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision medicine, digital therapeutics, gut microbiome testing, GLP-1 management, personalized nutrition
Industry4 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
  • Offices of Other Health Practitioners6213
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Therapeutics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Employer Health Benefits Contracts
TypeSubscription Recurring
Description

Digbi Health generates revenue through B2B contracts with self-insured employers, health plans, and TPAs. Pricing is structured with milestone-based fees at risk for ROI, with claims-based transparent reporting. Employers pay for obesity, GI, cardiometabolic care, and GLP-1 management programs as part of employee benefits.

digbihealth.ai
2Individual Consumer Subscriptions
TypeSubscription Recurring
Description

Direct-to-consumer revenue from individual members purchasing programs like Digbi Cares ($499 one-time for gut kit + gene kit + meal planner) with monthly health tracking and coaching. Additional subscription tiers include personalized prebiotics at $68.99/month.

digbihealth.com
3GLP-1 Medication Fulfillment
TypeTransaction Fee
Description

Revenue from GLP Compass platform facilitating GLP-1 prescriptions and fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels, with employer subsidies and cash-pay pathways through Digbi RxFund.

digbihealth.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Pricing details3 tiers
1Digbi Cares - Food-As-Medicine Program
ModelOne time/ perpetual licenseBilling cadenceMonthly
Notes

$499 one-time purchase includes Gut Kit + Gene Kit + Meal Planner + Health Tracking + Dedicated Coach. Monthly payment option starting at $45.08/month via Affirm financing.

digbihealth.com
2Digbi Control - Weight Loss Program
ModelSubscriptionBilling cadenceMonthly
Notes

$68.99/month subscription for personalized prebiotics and ongoing program access. Includes DNA test kit, gut microbiome test kit, Digbi Health App, coaching, genetic nutrition and fitness reports, probiotic report.

digbihealth.com
3Employer/Enterprise Contracts
ModelSubscriptionBilling cadenceAnnual
Notes

Milestone-based pricing with 100% of fees at risk for ROI. Financially de-risked model with verifiable, transparent claims-based reporting. Multiple years' claims analysis across self-insured employers demonstrates 9X ROI.

digbihealth.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 6 records shown
1Digbi Cares
Description

Food-as-Medicine care program for obesity, metabolic and digestive illnesses combining genetics, gut microbiome, and lifestyle interventions.

digbihealth.com
+5 more records
Core offering1 text field

Digbi Health operates a Precision Biology digital therapeutics platform that combines at-home genetic and gut microbiome testing with blood biomarkers and continuous glucose monitor data to deliver personalized food-as-medicine care programs for obesity, type 2 diabetes, GI disorders, and cardiometabolic conditions. The company sells standalone consumer programs (Digbi Care, Digbi Control, Digbi Digestive), GLP-1 medication management offerings (GLP Compass, GLP-Fit, Digbi RxFund), and B2B employer/health plan contracts with ROI guarantees. Services include telehealth consultations, dedicated coaching, mobile app tracking, and integration with Apple/Google Health, Dexcom CGM, and Fitbit devices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • 9.7% average weight loss without drugs; 18% with drugs
+14 more records
Product overview1 text field

Digbi Health operates as a multi-product digital therapeutics platform built around its proprietary Precision Biology™ framework. The core portfolio consists of two primary consumer programs—Digbi Cares (covering obesity, metabolic, and digestive health) and Digbi Digestive (focused on gastrointestinal care)—complemented by the weight-loss-specific Digbi Control offering. GLP Compass™ and GLP-Fit™ add GLP-1 medication management capabilities to the platform, while Digbi RxFund™ introduces financial pathways for employer-subsidized and cash-pay GLP-1 access. For employers, the platform consolidates multiple point solutions into a single precision care solution with ROI guarantees.

Product and service7 records
1Digbi Care (Digbi Cares)
CategoryCore consumer program
Description

Food-as-Medicine care program for adults with obesity, metabolic, and digestive illnesses that combines at-home gut-biome and genetic tests, screening of 65 blood biomarkers, connected devices (CGM, BP, body composition scale), biology-based food and lifestyle guidance, dedicated 24x7 coaching, and access to a private member community.

2Digbi Control
CategoryCore consumer program
Description

Subscription-based weight loss program (~$68.99/month) that uses gut microbiome and genetics-based digital care to identify and target root causes of obesity; includes DNA and gut test kits, personalized prebiotics, genetic nutrition and fitness reports, probiotic report, Digbi Mobile App, and dedicated coaching.

3Digbi Digestive
CategoryCore consumer program
Description

Digestive health program for adults with IBS, GERD, bloating, constipation, and related GI conditions that integrates gut microbiome and DNA-based personalized recommendations with monitoring, diagnostics, care coordination, and community support.

4GLP Compass™
CategoryGLP-1 management add-on
Description

GLP-1 medication management program combining GLP-1 prescriptions with Precision Biology care, including doctor access, labs, prescription fulfillment, side effect management (nausea, diarrhea, hair loss, muscle loss), and personalized care to minimize weight rebound after drug discontinuation; fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels.

5Digbi RxFund™
CategoryGLP-1 management add-on
Description

Financial innovation that gives employers and employees access to GLP-1 medications through subsidized, cash-pay, and traditional PBM pathways, creating predictable costs and supporting the full lifecycle of GLP-1 therapy in tandem with Precision Biology care.

6GLP-Fit™ Program
CategoryGLP-1 management add-on
Description

Program that expands the Precision Biology platform to incorporate GLP-1-based personalized care for obesity, combining GLP-1 medication management with Digbi's biology-based nutrition, coaching, and mobile tracking.

7Digbi Health Employer Program
CategoryEnterprise B2B offering
Description

Employer-facing digital care solution that consolidates obesity, cardiometabolic, diabetes, GI, and GLP-1 management for self-insured employers, health plans, and TPAs with simple contracting, minimal data exchange, turnkey claims billing, milestone-based pricing, and 100%-fees-at-risk ROI guarantees.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Novo Nordisk partnership focuses on precision biology for obesity prevention. Digbi Health's GLP Compass platform integrates with Novo Nordisk's GLP-1 medications, using precision biology to determine optimal GLP therapy and prevent unnecessary drug costs. ~30% of GLP-eligible employees choose not to start the drug through this program, delivering cost savings.

Strategic tierCoreTypeTechnology or Integration
Description

LabCorp partnership for laboratory testing services supporting Digbi Health's diagnostic capabilities including blood markers and metabolic panels integrated into the precision biology platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with Health Transformation Alliance for distribution of Digbi Health's precision biology programs to employer members.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership with Northwell Health for research collaboration and healthcare delivery integration.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Collective Health's platform announced September 2023 to integrate precision biology in streamlined healthcare benefits administration.

6Akesogen
Strategic tierCoreTypeTechnology or Integration
Description

CLIA-compliant laboratory partner Akesogen processes saliva samples for DNA sequencing and stool samples for gut microbiome analysis as part of Digbi Health's at-home testing kits.

digbihealth.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Financing partner Affirm enables monthly payment options for Digbi Health programs starting at $45.08/month, expanding accessibility for individual consumers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partnership with Stanford University in genetics and gut microbiome research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership with UCLA Health for research collaboration in precision health.

10CDC
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration with CDC on public health research related to obesity and chronic disease.

11HIMSS
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership with HIMSS for healthcare technology industry engagement and visibility.

digbihealth.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Solera health platform partnership for ecosystem integration and benefit navigation.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with LifeGroups for faith-based and community employer distribution.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership with WVU for research and workforce health programs.

15Dr. Ron Sinha / Cultural Health Solutions
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Corporate wellness expert Dr. Ron Sinha serves as advisor and refers patients to Digbi Health programs.

digbihealth.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor offering telehealth-based diabetes reversal and obesity care to employers and health plans, with validated clinical outcomes. Closest comparable in mission, business model, and B2B employer contracting with ROI guarantees.

TypeDirect peer
Description

Chronic disease prevention platform (diabetes, hypertension, obesity) sold to employers and health plans via B2B contracts. Directly comparable in customer base, revenue model, and condition focus, though Omada is broader and more established.

TypeDirect peer
Description

GLP-1-focused metabolic reset program combining medication with coaching for employer and consumer markets. Directly comparable GLP Compass offering and similar target buyer.

TypeDirect peer
Description

Weight care platform combining medication (including GLP-1s) with behavior change for consumers and employers. Comparable in chronic weight management and GLP-1 integration strategy.

5Noom
TypeBroad incumbent
Description

Established consumer and employer weight management platform with massive user base and brand recognition. Comparable in employer benefit distribution and chronic weight management, though Noom is broader and less biology-focused.

TypeBroad incumbent
Description

Major chronic condition management platform (diabetes, hypertension, weight) under Teladoc, serving employers and health plans. Comparable enterprise customer base and chronic care focus, though far larger and less personalized.

TypeEmerging player
Description

Personalized nutrition platform combining gut microbiome, blood markers, and dietary tracking for consumer health. Comparable precision biology approach (microbiome + blood), though primarily DTC and less employer-focused.

TypeEmerging player
Description

CGM-focused metabolic health platform for consumers and employers. Comparable in CGM integration and metabolic focus, though narrower in scope (CGM only, no genetics/microbiome).

TypeDirect peer
Description

Digital health benefit navigation platform connecting employers and payers with chronic disease prevention programs. Listed as Digbi partner, but also a competitor routing members to various point solutions.

TypeBroad incumbent
Description

Established weight management brand now expanding into GLP-1 medication programs for employers and consumers. Comparable employer benefit distribution and weight management focus with stronger consumer brand.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Digbi Health

Digital Therapeuticsdigbihealth.com

Digbi Health is a precision biology digital therapeutics company providing personalized chronic-disease care (obesity, type 2 diabetes, GI, and mental health) by integrating genetic, gut microbiome, blood biomarker, and CGM data for self-insured employers, health plans, and individual consumers.

What Digbi Health does

Digbi Health (legal entity FOOD RX AI INC.) is a precision biology digital therapeutics company headquartered at 800 El Camino Real West, Mountain View, California. Founded in 2017 by Ranjan Sinha, the company targets chronic metabolic, gastrointestinal, and mental-health conditions — primarily obesity, type 2 diabetes, IBS/GERD, and anxiety — that disproportionately drive employer healthcare spend. Its core offering is a multi-modal personalization platform that combines at-home genetic testing (600K variants via saliva), gut-microbiome analysis (stool swab through CLIA-compliant partner Akesogen), blood biomarkers, and continuous glucose monitor data into a unified member profile driving food-as-medicine recommendations.

The product portfolio spans Digbi Cares (obesity/metabolic/digestive), Digbi Digestive (GI-specific), Digbi Control (weight-loss subscription with personalized prebiotics at $68.99/month), and the GLP Compass suite — including GLP-Fit (Sep 2023) and Digbi RxFund (Mar 2026) — that integrates GLP-1 medication access and lifecycle management. A consumer subscription layer ($499 Digbi Cares one-time, or $45.08/month via Affirm financing) sits alongside a B2B enterprise channel with self-insured employers, health plans, and TPAs priced on milestone-based contracts with 100% of fees at risk against ROI claims.

Digbi monetizes through enterprise subscriptions (custom annual contracts with ROI guarantees, 9X actuarially validated ROI and $15,480 PMPY savings reported across seven employers), direct-to-consumer subscriptions and one-time kit sales, and GLP-1 transaction economics via the RxFund platform. Reported outcomes include 9.7% average weight loss without drugs, 18% with GLP-1s, 84% GI symptom improvement, 1.2% HbA1c reduction, and 63% mental-health improvement. Named enterprise customers include Blue Shield of California (23,500+ Wellvolution members), County of Ventura, and 300+ self-insured employers; strategic partners include Novo Nordisk, LabCorp, Collective Health, Health Transformation Alliance, Personify Health, and Dexcom.

Digbi Health firmographics

Firmographics
Name
Digbi Health
Legal name
FOOD RX AI INC.
Website
https://digbihealth.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Digbi Health is a precision biology digital therapeutics company providing personalized chronic-disease care (obesity, type 2 diabetes, GI, and mental health) by integrating genetic, gut microbiome, blood biomarker, and CGM data for self-insured employers, health plans, and individual consumers.
Ownership category
akta.pro rank

Digbi Health industry classification

Industry
Product category
Digital Therapeutics
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Other Health Practitioners (6213)
SIC
Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALADAD
Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN)
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
SECONDARYHLAHAHAJ
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Precision medicine
  • Digital therapeutics
  • Gut microbiome testing
  • GLP-1 management
  • Personalized nutrition

Where Digbi Health is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Digbi Health business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. Employer Health Benefits Contracts: Digbi Health generates revenue through B2B contracts with self-insured employers, health plans, and TPAs. Pricing is structured with milestone-based fees at risk for ROI, with claims-based transparent reporting. Employers pay for obesity, GI, cardiometabolic care, and GLP-1 management programs as part of employee benefits.
  2. Individual Consumer Subscriptions: Direct-to-consumer revenue from individual members purchasing programs like Digbi Cares ($499 one-time for gut kit + gene kit + meal planner) with monthly health tracking and coaching. Additional subscription tiers include personalized prebiotics at $68.99/month.
  3. GLP-1 Medication Fulfillment: Revenue from GLP Compass platform facilitating GLP-1 prescriptions and fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels, with employer subsidies and cash-pay pathways through Digbi RxFund.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMonthlyDigbi Cares - Food-As-Medicine Program
SubscriptionMonthlyDigbi Control - Weight Loss Program
SubscriptionAnnualEmployer/Enterprise Contracts

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Digbi Health product offering

Product offering

Core offering

Digbi Health operates a Precision Biology digital therapeutics platform that combines at-home genetic and gut microbiome testing with blood biomarkers and continuous glucose monitor data to deliver personalized food-as-medicine care programs for obesity, type 2 diabetes, GI disorders, and cardiometabolic conditions. The company sells standalone consumer programs (Digbi Care, Digbi Control, Digbi Digestive), GLP-1 medication management offerings (GLP Compass, GLP-Fit, Digbi RxFund), and B2B employer/health plan contracts with ROI guarantees. Services include telehealth consultations, dedicated coaching, mobile app tracking, and integration with Apple/Google Health, Dexcom CGM, and Fitbit devices.

Product overview

Digbi Health operates as a multi-product digital therapeutics platform built around its proprietary Precision Biology™ framework. The core portfolio consists of two primary consumer programs—Digbi Cares (covering obesity, metabolic, and digestive health) and Digbi Digestive (focused on gastrointestinal care)—complemented by the weight-loss-specific Digbi Control offering. GLP Compass™ and GLP-Fit™ add GLP-1 medication management capabilities to the platform, while Digbi RxFund™ introduces financial pathways for employer-subsidized and cash-pay GLP-1 access. For employers, the platform consolidates multiple point solutions into a single precision care solution with ROI guarantees.

Differentiator

Problem solved

Functional benefit

Brands

  • Digbi Cares: Food-as-Medicine care program for obesity, metabolic and digestive illnesses combining genetics, gut microbiome, and lifestyle interventions.
  • GLP Compass
  • Digbi Control
  • Digbi Digestive
  • Digbi RxFund
  • GLP-Fit

Products and services

  • Digbi Care (Digbi Cares) Food-as-Medicine care program for adults with obesity, metabolic, and digestive illnesses that combines at-home gut-biome and genetic tests, screening of 65 blood biomarkers, connected devices (CGM, BP, body composition scale), biology-based food and lifestyle guidance, dedicated 24x7 coaching, and access to a private member community.
  • Digbi Control Subscription-based weight loss program (~$68.99/month) that uses gut microbiome and genetics-based digital care to identify and target root causes of obesity; includes DNA and gut test kits, personalized prebiotics, genetic nutrition and fitness reports, probiotic report, Digbi Mobile App, and dedicated coaching.
  • Digbi Digestive Digestive health program for adults with IBS, GERD, bloating, constipation, and related GI conditions that integrates gut microbiome and DNA-based personalized recommendations with monitoring, diagnostics, care coordination, and community support.
  • GLP Compass™ GLP-1 medication management program combining GLP-1 prescriptions with Precision Biology care, including doctor access, labs, prescription fulfillment, side effect management (nausea, diarrhea, hair loss, muscle loss), and personalized care to minimize weight rebound after drug discontinuation; fulfillment across PBM, Direct to Employer, Employee Cash Pay, and 340B channels.
  • Digbi RxFund™ Financial innovation that gives employers and employees access to GLP-1 medications through subsidized, cash-pay, and traditional PBM pathways, creating predictable costs and supporting the full lifecycle of GLP-1 therapy in tandem with Precision Biology care.
  • GLP-Fit™ Program Program that expands the Precision Biology platform to incorporate GLP-1-based personalized care for obesity, combining GLP-1 medication management with Digbi's biology-based nutrition, coaching, and mobile tracking.
  • Digbi Health Employer Program Employer-facing digital care solution that consolidates obesity, cardiometabolic, diabetes, GI, and GLP-1 management for self-insured employers, health plans, and TPAs with simple contracting, minimal data exchange, turnkey claims billing, milestone-based pricing, and 100%-fees-at-risk ROI guarantees.

Quantifiable outcome

  • 9.7% average weight loss without drugs; 18% with drugs
  • +14 more outcomes

Companies that use Digbi Health

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Digbi Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature5 records

Digbi Health partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • Novo NordiskcoreStrategic or Co-development PartnerNovo Nordisk partnership focuses on precision biology for obesity prevention. Digbi Health's GLP Compass platform integrates with Novo Nordisk's GLP-1 medications, using precision biology to determine optimal GLP therapy and prevent unnecessary drug costs. ~30% of GLP-eligible employees choose not to start the drug through this program, delivering cost savings.
  • LabCorpcoreTechnology or IntegrationLabCorp partnership for laboratory testing services supporting Digbi Health's diagnostic capabilities including blood markers and metabolic panels integrated into the precision biology platform.
  • Health Transformation AlliancecoreChannel Partner/ Reseller/ DistributorPartnership with Health Transformation Alliance for distribution of Digbi Health's precision biology programs to employer members.
  • Northwell HealthminorStrategic or Co-development PartnerPartnership with Northwell Health for research collaboration and healthcare delivery integration.
  • Collective HealthcoreTechnology or IntegrationIntegration with Collective Health's platform announced September 2023 to integrate precision biology in streamlined healthcare benefits administration.
  • AkesogencoreTechnology or IntegrationCLIA-compliant laboratory partner Akesogen processes saliva samples for DNA sequencing and stool samples for gut microbiome analysis as part of Digbi Health's at-home testing kits.
  • AffirmminorGTM or Marketing PartnerFinancing partner Affirm enables monthly payment options for Digbi Health programs starting at $45.08/month, expanding accessibility for individual consumers.
  • StanfordminorStrategic or Co-development PartnerResearch partnership with Stanford University in genetics and gut microbiome research.
  • UCLA HealthminorStrategic or Co-development PartnerAcademic partnership with UCLA Health for research collaboration in precision health.
  • CDCminorStrategic or Co-development PartnerCollaboration with CDC on public health research related to obesity and chronic disease.
  • HIMSSminorGTM or Marketing PartnerPartnership with HIMSS for healthcare technology industry engagement and visibility.
  • SoleraminorChannel Partner/ Reseller/ DistributorSolera health platform partnership for ecosystem integration and benefit navigation.
  • LifeGroupsminorChannel Partner/ Reseller/ DistributorPartnership with LifeGroups for faith-based and community employer distribution.
  • West Virginia UniversityminorStrategic or Co-development PartnerAcademic partnership with WVU for research and workforce health programs.
  • Dr. Ron Sinha / Cultural Health SolutionsminorStrategic or Co-development PartnerCorporate wellness expert Dr. Ron Sinha serves as advisor and refers patients to Digbi Health programs.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Digbi Health competitors and assessment

Company assessment

Direct peers

  • Virta Health: Direct competitor offering telehealth-based diabetes reversal and obesity care to employers and health plans, with validated clinical outcomes. Closest comparable in mission, business model, and B2B employer contracting with ROI guarantees.
  • Omada Health: Chronic disease prevention platform (diabetes, hypertension, obesity) sold to employers and health plans via B2B contracts. Directly comparable in customer base, revenue model, and condition focus, though Omada is broader and more established.
  • Calibrate: GLP-1-focused metabolic reset program combining medication with coaching for employer and consumer markets. Directly comparable GLP Compass offering and similar target buyer.
  • Found: Weight care platform combining medication (including GLP-1s) with behavior change for consumers and employers. Comparable in chronic weight management and GLP-1 integration strategy.
  • Solera Health: Digital health benefit navigation platform connecting employers and payers with chronic disease prevention programs. Listed as Digbi partner, but also a competitor routing members to various point solutions.

Broad incumbents

  • Noom: Established consumer and employer weight management platform with massive user base and brand recognition. Comparable in employer benefit distribution and chronic weight management, though Noom is broader and less biology-focused.
  • Livongo (Teladoc Health): Major chronic condition management platform (diabetes, hypertension, weight) under Teladoc, serving employers and health plans. Comparable enterprise customer base and chronic care focus, though far larger and less personalized.
  • WW International (WeightWatchers): Established weight management brand now expanding into GLP-1 medication programs for employers and consumers. Comparable employer benefit distribution and weight management focus with stronger consumer brand.

Emerging players

  • Zoe: Personalized nutrition platform combining gut microbiome, blood markers, and dietary tracking for consumer health. Comparable precision biology approach (microbiome + blood), though primarily DTC and less employer-focused.
  • Levels Health: CGM-focused metabolic health platform for consumers and employers. Comparable in CGM integration and metabolic focus, though narrower in scope (CGM only, no genetics/microbiome).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Digbi Health social profiles

Digital presence

Digbi Health compliance and trust

Trust signal

Compliance4 records

Digbi Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Digbi Health leadership team

Management profile

Number of profiles

Profiles10 records

Digbi Health funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Digbi Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digbi Health

What does Digbi Health do?

Digbi Health operates a Precision Biology digital therapeutics platform that combines at-home genetic and gut microbiome testing with blood biomarkers and continuous glucose monitor data to deliver personalized food-as-medicine care programs for obesity, type 2 diabetes, GI disorders, and cardiometabolic conditions. The company sells standalone consumer programs (Digbi Care, Digbi Control, Digbi Digestive), GLP-1 medication management offerings (GLP Compass, GLP-Fit, Digbi RxFund), and B2B employer/health plan contracts with ROI guarantees. Services include telehealth consultations, dedicated coaching, mobile app tracking, and integration with Apple/Google Health, Dexcom CGM, and Fitbit devices.

Is Digbi Health a public or private company?

Digbi Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Digbi Health founded?

Digbi Health was founded in 2017. It employs 51 to 100 people.

Where is Digbi Health based?

Digbi Health is headquartered in Mountain View, United States, in the North America region.

How does Digbi Health make money?

Three revenue lines are on record. Employer Health Benefits Contracts are the primary driver. The others are individual Consumer Subscriptions and GLP-1 Medication Fulfillment.

Who are Digbi Health's main competitors?

Direct peers on record are Virta Health, Omada Health, Calibrate, Found and Solera Health. Broad incumbents are Noom, Livongo (Teladoc Health) and WW International (WeightWatchers). Emerging players are Zoe and Levels Health.

Does Digbi Health have an API?

No public API is recorded for Digbi Health.

What industry is Digbi Health in?

Digbi Health's product category is Digital Therapeutics. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN). Its NAICS code is 524292 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Longevity.TechnologyDigbi Health reports 18.4% weight loss in 3,181 GLP-1 usersDigbi Health reported a mean weight loss of 18.4% at 12 months among 3,181 members taking tirzepatide with its Precision Biology Lifestyle Care. The analysis spans members from 10 self-insured employers and compares to U.S. cohorts reporting 12.4% to 16.5% weight loss. The company will present findings at ObesityWeek 2026.FinancialContent Business PageDigbi Health Reports 18.4% Weight Loss With Tirzepatide, Challenges One-Size-Fits-All GLP-1 CareDigbi Health reported mean weight loss of 18.4% at 12 months among 3,181 members on tirzepatide with its Precision Biology Lifestyle Care, outperforming published cohorts on the same drug with standard care. The analysis spans 10 employers and will be presented at Obesity Week 2026.Business & FinancialDigbi Health Reports 18.4% Weight Loss With Tirzepatide, Challenges One-Size-Fits-All GLP-1 CareDigbi Health presented at ObesityWeek 2026 that its Tirzepatide members lost 18.4% of body weight over ~12 months. The analysis linked higher meal-quality scores to greater weight loss, with each point increase adding 2 percentage points. The company aims to make precision biology a standard part of GLP-1 care.Longevity.TechnologyDigbi’s ASRA puts AI agents on the care front lineDigbi Health announced ASRA, an agentic care operating system, on 28 October. The platform consolidates GLP-1, hormone therapy, and chronic disease coaching for employers, with AI agents handling operational tasks while clinicians retain clinical decisions. Digbi claims to serve over 300 employers and 30 million eligible people, though no outcome data for ASRA is disclosed.Longevity.TechnologyDigbi Health launches AI platform to treat obesity, diabetes, and gut healthDigbi Health announced ASRA, a precision biology-powered agentic care operating system for obesity, diabetes, hypertension, gastrointestinal disorders, and women's hormonal health. The platform integrates precision nutrition, lifestyle interventions, and pharmacotherapy, and powers programs for over 300 employers and health plans, reaching more than 30 million eligible individuals. The company reports third consecutive year revenue growth exceeding 100% while achieving profitability and positive cash flow.Business & FinancialDigbi Health Announces ASRA, A Precision Biology-Powered Agentic Care Operating System Unifying Metabolic, Inflammatory, And Hormonal HealthDigbi Health announced ASRA, an agentic care operating system unifying metabolic, inflammatory, and hormonal health. The platform serves over 300 employers and health plans, and Digbi reported its third consecutive year of revenue growth exceeding 100% and achieved profitability and positive cash flow.FinancialContent Business PageDigbi Health Announces ASRA, a Precision Biology-Powered Agentic Care Operating System Unifying Metabolic, Inflammatory, and Hormonal HealthDigbi Health announced ASRA, an agentic care operating system unifying metabolic, inflammatory, and hormonal health. The platform serves over 300 employers and health plans, and Digbi reported its third consecutive year of revenue growth exceeding 100% and achieved profitability and positive cash flow.GlobeNewswireDigbi Health Announces ASRA, a Precision Biology-Powered Agentic Care Operating System Unifying Metabolic, Inflammatory, and Hormonal HealthDigbi Health announced ASRA, an agentic care operating system unifying metabolic, inflammatory, and hormonal health. The platform serves over 300 employers and health plans, with revenue growth exceeding 100% for three consecutive years and profitability. ASRA is available nationwide across all 50 states.Longevity.TechnologyDigbi Health turns its gut data on menopauseDigbi Health added hormone replacement therapy to its Precision Biology platform, allowing GLP-1 and HRT prescriptions through one app. The company also reported IBS symptom scores dropping nearly 48 points at 12 weeks among 16,000 members, with results corrected for regression to the mean. The HRT offering is now available to existing employer and health plan contracts.Longevity.TechnologyDigbi Health expands precision biology care nationwideDigbi Health expanded its precision biology telehealth platform to all 50 states via OpenLoop Health and MD Integrations, giving members of over 300 employers and health plans access to more than 700 clinicians. The company reports a $3,012 reduction in overall medical spend per member per year, with the platform accessible to 30 million individuals.